CCCC

NASDAQStock

C4 Therapeutics, Inc.

$2.73-0.02 (-0.73%)

52-Week Range

$1.10
$3.59

Key Stats

Market Cap

202.3M

P/E Ratio

Dividend Yield

Beta

2.94

Volume

1.5M

Avg Volume

3.7M

Performance

1M

+45.50%

3M

+13.17%

6M

-19.35%

YTD

+42.49%

1Y

+31.58%

3Y

-33.89%

5Y

-93.70%

Price Chart

ETF Exposure

CCCC is held by 19 ETFs

ETFFund NameWeight
QQQSInvesco NASDAQ Future Gen 200 ETF0.53%
IWCiShares Micro-Cap ETF0.04%
PRFZInvesco RAFI US 1500 Small-Mid ETF0.03%
SBIO.LInvesco NASDAQ Biotech UCITS ETF0.02%
IBBQInvesco Nasdaq Biotechnology ETF0.02%
IBBiShares Biotechnology ETF0.02%
BIBProShares - Ultra Nasdaq Biotechnology0.01%
FESMFIDELITY ENHANCED SMALL CAP ETF0.01%
AVSCAvantis U.S. Small Cap Equity ETF0.01%
SCHASchwab U.S. Small-Cap ETF0.01%
DFASDimensional - US Small Cap ETF0.00%
VXFVanguard Extended Market ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%

About CCCC ETF Exposure

C4 Therapeutics, Inc. (CCCC) is held by 19 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 202.3M, CCCC is a widely held institutional stock. The stock currently trades at $2.73. Investors can gain exposure to CCCC through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CCCC, sorted by portfolio weight.